Kelly Financial Services’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$2.77K 685
2021
Q4
$2.77K Hold
100
﹤0.01% 505
2021
Q3
$3.1K Sell
100
-2,012
-95% -$48.3K ﹤0.01% 474
2021
Q2
$100K Buy
2,112
+2,012
+2,012% +$40.3K ﹤0.01% 377
2021
Q1
$2.02K Hold
100
﹤0.01% 500
2020
Q4
$1.6K Hold
100
﹤0.01% 483
2020
Q3
$1.24K Hold
100
﹤0.01% 470
2020
Q2
$712 Hold
100
﹤0.01% 519
2020
Q1
$543 Hold
100
﹤0.01% 498
2019
Q4
$905 Hold
100
﹤0.01% 479
2019
Q3
$719 Hold
100
﹤0.01% 474
2019
Q2
$795 Hold
100
﹤0.01% 432
2019
Q1
$1.26K Buy
+100
New +$1.58K ﹤0.01% 411

Other funds holding EVH

Kelly Financial Services's EVH Position: Q1 2022 in Review

Kelly Financial Services sold out of Evolent Health (EVH) in Q1 2022, closing a stake of 100 shares — an estimated $2.77K sold.

Kelly Financial Services first reported a position in EVH in Q1 2019 and held it in 12 quarters. The position peaked at $100K in Q2 2021. 218 funds tracked by Wall St. Rank hold EVH as of Q1 2022.

  • Kelly Financial Services reported no remaining Evolent Health position as of Q1 2022 after selling out during the quarter.
  • Kelly Financial Services sold 100 Evolent Health shares in Q1 2022, an estimated $2.77K.
  • Kelly Financial Services first reported a position in Evolent Health in Q1 2019 and held it in 12 quarters.
  • Kelly Financial Services's Evolent Health position peaked at $100K in Q2 2021.
  • 218 funds tracked by Wall St. Rank held Evolent Health as of Q1 2022.

Based on Kelly Financial Services's 13F filing for Q1 2022, filed 17 Jul 2024.